Temperature- and redox-responsive magnetic complex micelles for controlled drug release

2015 ◽  
Vol 3 (2) ◽  
pp. 260-269 ◽  
Author(s):  
Hui Zou ◽  
Weizhong Yuan

PCL-SS-PDMAEMA/Fe3O4 magnetic complex micelles can present dual temperature- and redox-responses, magnetism and magnetothermal properties.

2016 ◽  
Vol 7 (41) ◽  
pp. 6330-6339 ◽  
Author(s):  
Yingchun Xia ◽  
Hua He ◽  
Xiangyu Liu ◽  
Ding Hu ◽  
Lichen Yin ◽  
...  

We developed novel redox-responsive, core-crosslinked micelles (CCLMs) via a simple, one-step click chemistry reaction.


2016 ◽  
Vol 17 (4) ◽  
pp. 1600295 ◽  
Author(s):  
Caiyan Zhao ◽  
Leihou Shao ◽  
Jianqing Lu ◽  
Chenying Zhao ◽  
Yujie Wei ◽  
...  

2019 ◽  
Vol 3 (7) ◽  
pp. 1427-1432 ◽  
Author(s):  
Ya-Han Cui ◽  
Rong Deng ◽  
Zheng Li ◽  
Xu-Sheng Du ◽  
Qiong Jia ◽  
...  

Pillar[5]arene pseudo[1]rotaxane-based supramolecular vesicles loaded with anticancer drugs could deliver the payload to the targeted area of high GSH concentrations.


Pharmaceutics ◽  
2019 ◽  
Vol 12 (1) ◽  
pp. 26 ◽  
Author(s):  
Elisabetta Mazzotta ◽  
Selene De Benedittis ◽  
Antonio Qualtieri ◽  
Rita Muzzalupo

The clinical efficacy of methotrexate (MTX) is limited by its poor water solubility, its low bioavailability, and the development of resistance in cancer cells. Herein, we developed novel folate redox-responsive chitosan (FTC) nanoparticles for intracellular MTX delivery. l-Cysteine and folic acid molecules were selected to be covalently linked to chitosan in order to confer it redox responsiveness and active targeting of folate receptors (FRs). NPs based on these novel polymers could possess tumor specificity and a controlled drug release due to the overexpression of FRs and high concentration of reductive agents in the microenvironment of cancer cells. Nanoparticles (NPs) were prepared using an ionotropic gelation technique and characterized in terms of size, morphology, and loading capacity. In vitro drug release profiles exhibited a glutathione (GSH) dependence. In the normal physiological environment, NPs maintained good stability, whereas, in a reducing environment similar to tumor cells, the encapsulated MTX was promptly released. The anticancer activity of MTX-loaded FTC-NPs was also studied by incubating HeLa cells with formulations for various time and concentration intervals. A significant reduction in viability was observed in a dose- and time-dependent manner. In particular, FTC-NPs showed a better inhibition effect on HeLa cancer cell proliferation compared to non-target chitosan-based NPs used as control. The selective cellular uptake of FTC-NPs via FRs was evaluated and confirmed by fluorescence microscopy. Overall, the designed NPs provide an attractive strategy and potential platform for efficient intracellular anticancer drug delivery.


2009 ◽  
Vol 9 (12) ◽  
pp. 1185-1193 ◽  
Author(s):  
Chenglin Wu ◽  
Rujiang Ma ◽  
Huan He ◽  
Lizhi Zhao ◽  
Hongjun Gao ◽  
...  

2014 ◽  
Vol 292 (7) ◽  
pp. 1675-1683 ◽  
Author(s):  
Lizhi Zhao ◽  
Chenglin Wu ◽  
Fang Wang ◽  
Anguo Ying ◽  
Chendiao Xu ◽  
...  

2019 ◽  
Vol 7 (2) ◽  
pp. 607-617 ◽  
Author(s):  
Sussana A. Elkassih ◽  
Petra Kos ◽  
Hu Xiong ◽  
Daniel J. Siegwart

Stimuli-responsive nanogels degrade to small molecules in reducing environments to mediate controlled drug release.


Sign in / Sign up

Export Citation Format

Share Document